Medical and surgical treatment of parapneumonic effusions : an evidence-based guideline
- PMID: 11035692
- DOI: 10.1378/chest.118.4.1158
Medical and surgical treatment of parapneumonic effusions : an evidence-based guideline
Erratum in
- Chest 2001 Jan;119(1):319
Abstract
Objective: A panel was convened by the Health and Science Policy Committee of the American College of Chest Physicians to develop a clinical practice guideline on the medical and surgical treatment of parapneumonic effusions (PPE) using evidence-based methods.
Options and outcomes considered: Based on consensus of clinical opinion, the expert panel developed an annotated table for evaluating the risk for poor outcome in patients with PPE. Estimates of the risk for poor outcome were based on the clinical judgment that, without adequate drainage of the pleural space, the patient with PPE would be likely to have any or all of the following: prolonged hospitalization, prolonged evidence of systemic toxicity, increased morbidity from any drainage procedure, increased risk for residual ventilatory impairment, increased risk for local spread of the inflammatory reaction, and increased mortality. Three variables, pleural space anatomy, pleural fluid bacteriology, and pleural fluid chemistry, were used in this annotated table to categorize patients into four separate risk levels for poor outcome: categories 1 (very low risk), 2 (low risk), 3 (moderate risk), and 4 (high risk). The panel's consensus opinion supported drainage for patients with moderate (category 3) or high (category 4) risk for a poor outcome, but not for patients with very low (category 1) or low (category 2) risk for a poor outcome. The medical literature was reviewed to evaluate the effectiveness of medical and surgical management approaches for patients with PPE at moderate or high risk for poor outcome. The panel grouped PPE management approaches into six categories: no drainage performed, therapeutic thoracentesis, tube thoracostomy, fibrinolytics, video-assisted thoracoscopic surgery (VATS), and surgery (including thoracotoiny with or without decortication and rib resection). The fibrinolytic approach required tube thoracostomy for administration of drug, and VATS included post-procedure tube thoracostomy. Surgery may have included concomitant lung resection and always included postoperative tube thoracostomy. All management approaches included appropriate treatment of the underlying pneumonia, including systemic antibiotics. Criteria for including articles in the panel review were adequate data provided for >/=20 adult patients with PPE to allow evaluation of at least one relevant outcome (death or need for a second intervention to manage the PPE); reasonable assurance provided that drainage was clinically appropriate (patients receiving drainage were either category 3 or category 4) and drainage procedure was adequately described; and original data were presented. The strength of panel recommendations on management of PPE was based on the following approach: level A, randomized, controlled trials with consistent results or individual randomized, controlled trial with narrow confidence interval (CI); level B, controlled cohort and case control series; level C, historically controlled series and case series; and level D, expert opinion without explicit critical appraisal or based on physiology, bench research, or "first principles."
Evidence: The literature review revealed 24 articles eligible for full review by the panel, 19 of which dealt with the primary management approach to PPE and 5 with a rescue approach after a previous approach had failed. Of the 19 involving the primary management approach to PPE, there were 3 randomized, controlled trials, 2 historically controlled series, and 14 case series. The number of patients included in the randomized controlled trials was small; methodologic weaknesses were found in the 19 articles describing the results of primary management approaches to PPE. The proportion and 95% CI of patients suffering each of the two relevant outcomes (death and need for a second intervention to manage the PPE) were calculated for the pooled data for each management approach from the 19 articles on the primary management approach. (ABST
Similar articles
-
Surgical versus non-surgical management for pleural empyema.Cochrane Database Syst Rev. 2017 Mar 17;3(3):CD010651. doi: 10.1002/14651858.CD010651.pub2. Cochrane Database Syst Rev. 2017. PMID: 28304084 Free PMC article. Review.
-
Current evidence for the management of paediatric parapneumonic effusions.Curr Med Res Opin. 2012 Jul;28(7):1179-92. doi: 10.1185/03007995.2012.684674. Epub 2012 May 22. Curr Med Res Opin. 2012. PMID: 22502916 Review.
-
Comparative analysis of chest tube thoracostomy and video-assisted thoracoscopic surgery in empyema and parapneumonic effusion associated with pneumonia in children.Surg Infect (Larchmt). 2008 Jun;9(3):317-23. doi: 10.1089/sur.2007.025. Surg Infect (Larchmt). 2008. PMID: 18570573
-
Trends in treatment of infectious parapneumonic effusions in U.S. children's hospitals, 2004-2014.J Pediatr Surg. 2016 Jun;51(6):885-90. doi: 10.1016/j.jpedsurg.2016.02.047. Epub 2016 Mar 5. J Pediatr Surg. 2016. PMID: 27032611
-
Image-guided management of complicated pleural fluid collections.Radiol Clin North Am. 2000 Mar;38(2):345-74. doi: 10.1016/s0033-8389(05)70167-6. Radiol Clin North Am. 2000. PMID: 10765394 Review.
Cited by
-
Salmonella pneumonia and empyema in a patient with end-stage liver disease.Respir Med Case Rep. 2024 Sep 27;52:102125. doi: 10.1016/j.rmcr.2024.102125. eCollection 2024. Respir Med Case Rep. 2024. PMID: 39502447 Free PMC article.
-
Comparison of the effect of chest tube diameter on drainage rate and tube performance in patients with pleural effusion. A cross-sectional study.Kardiochir Torakochirurgia Pol. 2024 Sep;21(3):162-166. doi: 10.5114/kitp.2024.143489. Epub 2024 Sep 25. Kardiochir Torakochirurgia Pol. 2024. PMID: 39484110 Free PMC article.
-
Chest ultrasound is better than CT in identifying septated effusion of patients with pleural disease.Sci Rep. 2024 May 25;14(1):11964. doi: 10.1038/s41598-024-62807-4. Sci Rep. 2024. PMID: 38796511 Free PMC article.
-
Progression of Community-Acquired Pneumonia in a Morbidly Obese Patient With a History of Vaping and Asthma: A Multidisciplinary Approach to Management.Cureus. 2024 Apr 8;16(4):e57828. doi: 10.7759/cureus.57828. eCollection 2024 Apr. Cureus. 2024. PMID: 38721182 Free PMC article.
-
Benefit of intrapleural fibrinolytic therapy in the treatment of complicated parapneumonic effusion and empyema.Pan Afr Med J. 2024 Feb 8;47:54. doi: 10.11604/pamj.2024.47.54.15439. eCollection 2024. Pan Afr Med J. 2024. PMID: 38646137 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
